In the lead up to the Oncology Europe Summit I'll be releasing exclusive pieces of content on the issues that matter most to you.

Just fill in the details on the right and you'll receive an email with a link to all the content below.

AVAILABLE NOW!

• 1. Presentation slides from Oncology USA 2012: From evidence-based to value-based medicines:

What does this mean for your development strategy? - Darshan Wariabharaj, Director, Drug Regulatory Affairs, Novartis Oncology
What does this mean for your commercialization strategy? - Quanwu Zhang, Global Evidence & Value Development, Sanofi R&D

• 2. Presentation slides from Oncology USA 2011: Mind the gap! The growing gap between the requirements of payers and regulators - Uday Bose, European Head of Oncology, Eisai

Learn how to satisfy regulators and payers and save money with a holistic market access strategy

Coming Up Next Week...

Exclusive podcast: Value Based Pricing and the Cancer Drugs Fund - Omar Ali, Formulary Development Pharmacist and Cost Impact Modelling Consultant, NHS/NICE

If the content is useful to you, remember to check out the Oncology Europe Summit online here!